The coronary atherectomy devices market size has grown rapidly in recent years. It will grow from $0.23 billion in 2025 to $0.26 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising incidence of coronary artery disease, increased use of interventional cardiology procedures, expansion of catheterization laboratories, growing aging population, clinical validation of atherectomy techniques.
The coronary atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $0.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for complex coronary interventions, rising adoption of image-guided cardiovascular procedures, growing investments in cardiac care infrastructure, technological advancements in device precision, expansion of minimally invasive treatment protocols. Major trends in the forecast period include increasing use of advanced rotational atherectomy devices, rising adoption of minimally invasive coronary procedures, growing focus on calcified lesion treatment, expansion of precision-controlled atherectomy systems, enhanced integration with imaging-guided interventions.
The increasing prevalence of cardiovascular diseases (CVDs) is driving the growth of the coronary atherectomy devices market going forward. Cardiovascular diseases encompass a group of disorders affecting the heart and blood vessels, often resulting from plaque buildup, restricted blood flow, and progressive arterial narrowing. The rising burden of CVDs is largely attributed to the growing prevalence of modifiable risk factors such as hypertension, obesity, diabetes, unhealthy diets, physical inactivity, and tobacco use. This expanding disease burden is increasing the demand for coronary atherectomy devices, as these minimally invasive tools are critical for effectively removing calcified or complex plaque, restoring optimal blood flow, and improving procedural success rates during percutaneous coronary interventions (PCI). For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based public health institute, in 2023, approximately 1 out of every 6 deaths from cardiovascular diseases occurred among adults younger than 65 years, and a total of 919,032 people died from cardiovascular disease, accounting for 1 in every 3 deaths. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the global coronary atherectomy devices market.
Leading companies in the coronary atherectomy equipment market are emphasizing innovative solutions, such as radial access catheters, to enhance patient outcomes by enabling safer and less invasive treatments for coronary artery disease. Radial access catheters are specialized devices used in interventional cardiology to access coronary arteries via the radial artery in the wrist, as opposed to the traditional femoral artery in the groin. For example, in January 2024, AngioDynamics, a US-based provider of healthcare products and solutions, received FDA 510(k) clearance for its Auryon XL Radial Access Catheter, developed for the treatment of peripheral arterial disease (PAD). This 225-cm catheter, compatible with the Auryon Atherectomy System, is available in two diameters (0.9 mm and 1.5 mm) and leverages advanced laser technology for effective arterial occlusion treatment. Radial access offers significant advantages, including a lower risk of major bleeding compared to femoral access and the ability to treat bilateral disease in a single session, facilitating quicker patient recovery.
In April 2023, Abbott Laboratories, a US-based medical device firm, finalized the acquisition of Cardiovascular Systems, Inc. for $890 million. Through this acquisition, Abbott aims to enhance their capacity to cater to patients dealing with peripheral and coronary artery disease, particularly by preparing the arteries for angioplasty or stenting procedures to restore adequate blood flow. Cardiovascular Systems, Inc., a US-based medical device company, specializes in developing advanced treatments for coronary artery disease and challenging peripheral vascular conditions.
Major companies operating in the coronary atherectomy devices market are Boston Scientific Corporation, Cardiovascular Systems Inc., The Spectranetics Corporation, Medtronic Inc., Avinger Inc., Biotronik SE & Co. KG, Arterial Remodeling Technologies, Straub Medical AG, RA Medical Systems Inc., Shockwave Medical Inc., Terumo Corporation, Abbott Laboratories Inc., Asahi Intecc Co. Ltd., Baylis Medical Company Inc., Cook Medical LLC, Cordis Corporation, Infraredx Inc., Intact Vascular Inc., TriReme Medical LLC, Volcano Corporation.
North America was the largest region in the coronary atherectomy devices market in 2025. Western Europe was the second-largest region in the global coronary atherectomy devices market share. Africa, was the smallest region in the coronary atherectomy devices industry. The regions covered in the coronary atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coronary atherectomy devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the coronary atherectomy devices market by increasing costs of imported precision motors, micro-drives, catheters, sensors, and specialty metals used in atherectomy systems. Hospitals and cardiac surgical centers in North America and Europe are most affected due to dependence on imported high-precision cardiovascular devices, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are raising procedure costs and slowing adoption in cost-sensitive markets. However, they are also encouraging regional manufacturing, local assembly of components, and innovation in cost-efficient atherectomy device designs.
The coronary atherectomy devices market research report is one of a series of new reports that provides coronary atherectomy devices market statistics, including coronary atherectomy devices industry global market size, regional shares, competitors with a coronary atherectomy devices market share, detailed coronary atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the coronary atherectomy devices industry. This coronary atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Coronary atherectomy devices serve the purpose of removing atherosclerosis from coronary blood vessels. These devices are specifically engineered to eliminate atheroma, calcium, and excess cellular material from areas of coronary occlusion or stenosis.
The primary products in coronary atherectomy devices include directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, among others. Rotational atherectomy devices, for instance, consist of a lengthy catheter housing a microscopic diamond-embedded, oval-shaped burr for the purpose of effectively addressing coronary conditions. These devices are widely utilized across various applications such as peripheral vascular, cardiovascular, and neurovascular treatments. They are employed by a range of end-users, including hospitals, surgical centers, ambulatory care facilities, research laboratories, and academic institutes.
The coronary atherectomy devices market consists of sales of directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and others that are used to treat coronary atherectomy. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The coronary atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $0.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for complex coronary interventions, rising adoption of image-guided cardiovascular procedures, growing investments in cardiac care infrastructure, technological advancements in device precision, expansion of minimally invasive treatment protocols. Major trends in the forecast period include increasing use of advanced rotational atherectomy devices, rising adoption of minimally invasive coronary procedures, growing focus on calcified lesion treatment, expansion of precision-controlled atherectomy systems, enhanced integration with imaging-guided interventions.
The increasing prevalence of cardiovascular diseases (CVDs) is driving the growth of the coronary atherectomy devices market going forward. Cardiovascular diseases encompass a group of disorders affecting the heart and blood vessels, often resulting from plaque buildup, restricted blood flow, and progressive arterial narrowing. The rising burden of CVDs is largely attributed to the growing prevalence of modifiable risk factors such as hypertension, obesity, diabetes, unhealthy diets, physical inactivity, and tobacco use. This expanding disease burden is increasing the demand for coronary atherectomy devices, as these minimally invasive tools are critical for effectively removing calcified or complex plaque, restoring optimal blood flow, and improving procedural success rates during percutaneous coronary interventions (PCI). For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based public health institute, in 2023, approximately 1 out of every 6 deaths from cardiovascular diseases occurred among adults younger than 65 years, and a total of 919,032 people died from cardiovascular disease, accounting for 1 in every 3 deaths. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the global coronary atherectomy devices market.
Leading companies in the coronary atherectomy equipment market are emphasizing innovative solutions, such as radial access catheters, to enhance patient outcomes by enabling safer and less invasive treatments for coronary artery disease. Radial access catheters are specialized devices used in interventional cardiology to access coronary arteries via the radial artery in the wrist, as opposed to the traditional femoral artery in the groin. For example, in January 2024, AngioDynamics, a US-based provider of healthcare products and solutions, received FDA 510(k) clearance for its Auryon XL Radial Access Catheter, developed for the treatment of peripheral arterial disease (PAD). This 225-cm catheter, compatible with the Auryon Atherectomy System, is available in two diameters (0.9 mm and 1.5 mm) and leverages advanced laser technology for effective arterial occlusion treatment. Radial access offers significant advantages, including a lower risk of major bleeding compared to femoral access and the ability to treat bilateral disease in a single session, facilitating quicker patient recovery.
In April 2023, Abbott Laboratories, a US-based medical device firm, finalized the acquisition of Cardiovascular Systems, Inc. for $890 million. Through this acquisition, Abbott aims to enhance their capacity to cater to patients dealing with peripheral and coronary artery disease, particularly by preparing the arteries for angioplasty or stenting procedures to restore adequate blood flow. Cardiovascular Systems, Inc., a US-based medical device company, specializes in developing advanced treatments for coronary artery disease and challenging peripheral vascular conditions.
Major companies operating in the coronary atherectomy devices market are Boston Scientific Corporation, Cardiovascular Systems Inc., The Spectranetics Corporation, Medtronic Inc., Avinger Inc., Biotronik SE & Co. KG, Arterial Remodeling Technologies, Straub Medical AG, RA Medical Systems Inc., Shockwave Medical Inc., Terumo Corporation, Abbott Laboratories Inc., Asahi Intecc Co. Ltd., Baylis Medical Company Inc., Cook Medical LLC, Cordis Corporation, Infraredx Inc., Intact Vascular Inc., TriReme Medical LLC, Volcano Corporation.
North America was the largest region in the coronary atherectomy devices market in 2025. Western Europe was the second-largest region in the global coronary atherectomy devices market share. Africa, was the smallest region in the coronary atherectomy devices industry. The regions covered in the coronary atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coronary atherectomy devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the coronary atherectomy devices market by increasing costs of imported precision motors, micro-drives, catheters, sensors, and specialty metals used in atherectomy systems. Hospitals and cardiac surgical centers in North America and Europe are most affected due to dependence on imported high-precision cardiovascular devices, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are raising procedure costs and slowing adoption in cost-sensitive markets. However, they are also encouraging regional manufacturing, local assembly of components, and innovation in cost-efficient atherectomy device designs.
The coronary atherectomy devices market research report is one of a series of new reports that provides coronary atherectomy devices market statistics, including coronary atherectomy devices industry global market size, regional shares, competitors with a coronary atherectomy devices market share, detailed coronary atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the coronary atherectomy devices industry. This coronary atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Coronary atherectomy devices serve the purpose of removing atherosclerosis from coronary blood vessels. These devices are specifically engineered to eliminate atheroma, calcium, and excess cellular material from areas of coronary occlusion or stenosis.
The primary products in coronary atherectomy devices include directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, among others. Rotational atherectomy devices, for instance, consist of a lengthy catheter housing a microscopic diamond-embedded, oval-shaped burr for the purpose of effectively addressing coronary conditions. These devices are widely utilized across various applications such as peripheral vascular, cardiovascular, and neurovascular treatments. They are employed by a range of end-users, including hospitals, surgical centers, ambulatory care facilities, research laboratories, and academic institutes.
The coronary atherectomy devices market consists of sales of directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and others that are used to treat coronary atherectomy. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Coronary Atherectomy Devices Market Characteristics
3. Coronary Atherectomy Devices Market Supply Chain Analysis
4. Global Coronary Atherectomy Devices Market Trends and Strategies
5. Coronary Atherectomy Devices Market Analysis of End Use Industries
7. Global Coronary Atherectomy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Coronary Atherectomy Devices Total Addressable Market (TAM) Analysis for the Market
9. Coronary Atherectomy Devices Market Segmentation
10. Coronary Atherectomy Devices Market Regional and Country Analysis
11. Asia-Pacific Coronary Atherectomy Devices Market
12. China Coronary Atherectomy Devices Market
13. India Coronary Atherectomy Devices Market
14. Japan Coronary Atherectomy Devices Market
15. Australia Coronary Atherectomy Devices Market
16. Indonesia Coronary Atherectomy Devices Market
17. South Korea Coronary Atherectomy Devices Market
18. Bangladesh Coronary Atherectomy Devices Market
19. Thailand Coronary Atherectomy Devices Market
20. Vietnam Coronary Atherectomy Devices Market
21. Malaysia Coronary Atherectomy Devices Market
22. Singapore Coronary Atherectomy Devices Market
23. Philippines Coronary Atherectomy Devices Market
24. Hong Kong Coronary Atherectomy Devices Market
25. New Zealand Coronary Atherectomy Devices Market
26. Taiwan Coronary Atherectomy Devices Market
27. South East Asia Coronary Atherectomy Devices Market
28. Western Europe Coronary Atherectomy Devices Market
29. UK Coronary Atherectomy Devices Market
30. Germany Coronary Atherectomy Devices Market
31. France Coronary Atherectomy Devices Market
32. Italy Coronary Atherectomy Devices Market
33. Spain Coronary Atherectomy Devices Market
34. Austria Coronary Atherectomy Devices Market
35. Belgium Coronary Atherectomy Devices Market
36. Denmark Coronary Atherectomy Devices Market
37. Finland Coronary Atherectomy Devices Market
38. Ireland Coronary Atherectomy Devices Market
39. Netherlands Coronary Atherectomy Devices Market
40. Norway Coronary Atherectomy Devices Market
41. Portugal Coronary Atherectomy Devices Market
42. Sweden Coronary Atherectomy Devices Market
42. Switzerland Coronary Atherectomy Devices Market
43. Eastern Europe Coronary Atherectomy Devices Market
44. Russia Coronary Atherectomy Devices Market
45. Czech Republic Coronary Atherectomy Devices Market
46. Poland Coronary Atherectomy Devices Market
47. Romania Coronary Atherectomy Devices Market
48. Ukraine Coronary Atherectomy Devices Market
49. North America Coronary Atherectomy Devices Market
50. USA Coronary Atherectomy Devices Market
51. Canada Coronary Atherectomy Devices Market
52. Mexico Coronary Atherectomy Devices Market
53. South America Coronary Atherectomy Devices Market
54. Brazil Coronary Atherectomy Devices Market
55. Chile Coronary Atherectomy Devices Market
56. Argentina Coronary Atherectomy Devices Market
57. Colombia Coronary Atherectomy Devices Market
58. Peru Coronary Atherectomy Devices Market
59. Middle East Coronary Atherectomy Devices Market
60. Saudi Arabia Coronary Atherectomy Devices Market
61. Israel Coronary Atherectomy Devices Market
62. Iran Coronary Atherectomy Devices Market
63. Turkey Coronary Atherectomy Devices Market
64. United Arab Emirates Coronary Atherectomy Devices Market
65. Africa Coronary Atherectomy Devices Market
66. Egypt Coronary Atherectomy Devices Market
67. Nigeria Coronary Atherectomy Devices Market
68. South Africa Coronary Atherectomy Devices Market
70. Coronary Atherectomy Devices Market Competitive Landscape and Company Profiles
71. Coronary Atherectomy Devices Market Other Major and Innovative Companies
74. Coronary Atherectomy Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Coronary Atherectomy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses coronary atherectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for coronary atherectomy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coronary atherectomy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Directional Atherectomy Devices; Orbital Atherectomy Devices; Photo-Ablative Atherectomy Devices; Rotational Atherectomy Devices; Other Products2) By Application: Peripheral Vascular; Cardiovascular; Coronary Artery Disease
3) By End User: Hospitals And Surgical Centers; Ambulatory Care Centers; Cardiac Specialty Centers
Subsegments:
1) By Directional Atherectomy Devices: Traditional Directional Atherectomy Devices; Advanced Directional Atherectomy Devices2) By Orbital Atherectomy Devices: Single-Wire Orbital Atherectomy Devices; Multi-Wire Orbital Atherectomy Devices
3) By Photo-Ablative Atherectomy Devices: Laser-Based Photo-Ablative Devices; Other Photo-Ablative Atherectomy Devices
4) By Rotational Atherectomy Devices: Manual Rotational Atherectomy Devices; Motorized Rotational Atherectomy Devices
5) By Other Products: Combination Atherectomy Devices; Custom Atherectomy Solutions; Other Coronary Atherectomy Devices
Companies Mentioned: Boston Scientific Corporation; Cardiovascular Systems Inc.; The Spectranetics Corporation; Medtronic Inc.; Avinger Inc.; Biotronik SE & Co. KG; Arterial Remodeling Technologies; Straub Medical AG; RA Medical Systems Inc.; Shockwave Medical Inc.; Terumo Corporation; Abbott Laboratories Inc.; Asahi Intecc Co. Ltd.; Baylis Medical Company Inc.; Cook Medical LLC; Cordis Corporation; Infraredx Inc.; Intact Vascular Inc.; TriReme Medical LLC; Volcano Corporation
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Coronary Atherectomy Devices market report include:- Boston Scientific Corporation
- Cardiovascular Systems Inc.
- The Spectranetics Corporation
- Medtronic Inc.
- Avinger Inc.
- Biotronik SE & Co. KG
- Arterial Remodeling Technologies
- Straub Medical AG
- RA Medical Systems Inc.
- Shockwave Medical Inc.
- Terumo Corporation
- Abbott Laboratories Inc.
- Asahi Intecc Co. Ltd.
- Baylis Medical Company Inc.
- Cook Medical LLC
- Cordis Corporation
- Infraredx Inc.
- Intact Vascular Inc.
- TriReme Medical LLC
- Volcano Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.26 Billion |
| Forecasted Market Value ( USD | $ 0.37 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
